Close Menu

IPO

NEW YORK (GenomeWeb News) – Synthetic biology firm Intrexon has filed to raise up to $125 million in an initial public offering.

NEW YORK (GenomeWeb News) – NanoString Technologies late on Tuesday priced its planned initial public offering at $10 per share.

NEW YORK (GenomeWeb News) – NanoString Technologies today said that it anticipates raising as much as $77.6 million in its initial public offering.

NEW YORK (GenomeWeb News) – Stem cell technologies company Cellular Dynamics International today announced it has filed with the US Securities and Exchange Commission to go public.

NEW YORK (GenomeWeb News) – Translational life science tools and molecular diagnostics company NanoString Technologies today filed for an initial public offering.

NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market on Friday that the underwriters of its initial public offering have exercised in full their over-allotment option to purc

NEW YORK (GenomeWeb News) – Cancer Genetics priced its initial public offering at $10 per share today, expecting to raise gross proceeds of $6 million.

NEW YORK (GenomeWeb News) – Since its founding in 2005, molecular diagnostics firm Great Basin has raised $36 million in private financing, including about $9.6 million in a Series B round completed

NEW YORK (GenomeWeb News) – Cancer Genetics today announced that Gilead Sciences has selected it to provide clinical trial services and molecular profiling of chronic lymphocytic leukemia patients.

NEW YORK (GenomeWeb News) – Cancer Genetics again lowered the amount it expects to raise in its pending initial public offering.

Pages

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.